Insider Trading activities of Questcor Pharmaceuticals Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Questcor Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Questcor Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Questcor Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is QCOR. The reporting company's CIK number is 891288.
The total value of stock buying since 2005 is $32,593,057.
The total value of stock sales since 2005 is $303,768,618.
The total value of stock option exercises since 2005 is $18,510,612.


Go to page:  1   2 

Table 2. Detailed insider stock purchases, sales, and option exercises of Questcor Pharmaceuticals Inc insiders (QCOR) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-07-10 Bailey Don M (President & CEO) Sale 30,000 57.74 1,732,080
2012-07-10 Bailey Don M (President & CEO) Option Ex 30,000 2.76 82,950
2012-07-02 Blutt Mitchell J Md (Director) Sale 70,000 53.11 3,717,980
2012-06-11 Bailey Don M (President & CEO) Sale 30,000 45.37 1,361,130
2012-06-11 Bailey Don M (President & CEO) Option Ex 30,000 .44 13,200
2012-05-23 Mulroy Michael H. (Sr VP, CFO & General Counsel) Buy 1,000 40.00 40,000
2012-05-10 Bailey Don M (President & CEO) Sale 30,000 39.66 1,189,650
2012-05-10 Bailey Don M (President & CEO) Option Ex 30,000 .44 13,200
2012-05-04 Blutt Mitchell J Md (Director) Sale 11,573 42.69 494,051
2012-05-04 Blutt Mitchell J Md (Director) Option Ex 11,573 10.16 117,581
2012-04-27 Young David (Chief Scientific Officer) Sale 70,000 42.81 2,996,700
2012-04-27 Young David (Chief Scientific Officer) Option Ex 70,000 4.54 317,800
2012-04-19 Farrell Stephen C (Director) Sale 25,000 42.00 1,050,000
2012-04-19 Farrell Stephen C (Director) Option Ex 25,000 1.92 48,000
2012-04-10 Bailey Don M (President & CEO) Sale 30,000 40.92 1,227,600
2012-04-10 Bailey Don M (President & CEO) Option Ex 30,000 .44 13,200
2012-03-09 Bailey Don M (President & CEO) Sale 30,000 36.12 1,083,510
2012-03-09 Bailey Don M (President & CEO) Option Ex 30,000 .44 13,200
2012-02-10 Bailey Don M (President & CEO) Sale 30,000 34.78 1,043,400
2012-02-10 Bailey Don M (President & CEO) Option Ex 30,000 .44 13,200
2012-01-10 Bailey Don M (President & CEO) Sale 30,000 41.87 1,256,100
2012-01-10 Bailey Don M (President & CEO) Option Ex 30,000 .44 13,200
2011-12-09 Bailey Don M (President & CEO) Sale 30,000 44.09 1,322,790
2011-12-09 Bailey Don M (President & CEO) Option Ex 30,000 .44 13,200
2011-11-16 Farrell Stephen C (Director) Sale 30,000 43.47 1,304,100
2011-11-15 Blutt Mitchell J Md (Director) Sale 150,000 43.94 6,591,000
2011-11-14 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Sale 50,572 43.99 2,224,662
2011-11-14 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Option Ex 50,572 1.37 69,283
2011-11-11 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Sale 123,036 42.98 5,288,087
2011-11-11 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Option Ex 123,036 .71 87,355
2011-11-10 Bailey Don M (President & CEO) Sale 30,000 41.44 1,243,200
2011-11-10 Bailey Don M (President & CEO) Option Ex 30,000 .44 13,200
2011-11-08 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Sale 180,189 42.57 7,670,645
2011-11-08 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Option Ex 180,189 .89 160,548
2011-11-08 Cartt Stephen Lahue (Executive VP & CBO) Sale 8,100 42.75 346,275
2011-11-08 Cartt Stephen Lahue (Executive VP & CBO) Option Ex 8,100 5.09 41,229
2011-10-31 Young David (Chief Scientific Officer) Sale 79,724 41.22 3,285,824
2011-10-31 Young David (Chief Scientific Officer) Option Ex 75,000 4.54 340,500
2011-10-31 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Sale 62,469 42.46 2,652,121
2011-10-31 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Option Ex 7,248 .74 5,399
2011-10-31 Cartt Stephen Lahue (Executive VP & CBO) Sale 25,000 42.60 1,065,000
2011-10-31 Cartt Stephen Lahue (Executive VP & CBO) Option Ex 25,000 5.09 127,250
2011-10-28 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Sale 147,756 41.55 6,139,261
2011-10-28 Cartt Stephen Lahue (Executive VP & CBO) Sale 139,286 41.36 5,760,868
2011-10-28 Cartt Stephen Lahue (Executive VP & CBO) Option Ex 139,286 2.86 398,079
2011-10-10 Bailey Don M (President & CEO) Sale 30,000 31.94 958,200
2011-10-10 Bailey Don M (President & CEO) Option Ex 30,000 1.13 33,810
2011-09-12 Bailey Don M (President & CEO) Sale 30,000 27.16 814,680
2011-09-12 Bailey Don M (President & CEO) Option Ex 30,000 1.58 47,340
2011-09-12 Blutt Mitchell J Md (Director) Sale 370,000 26.13 9,668,470
2011-09-02 Engelke Kristine (Corp. Controller & PAO) Sale 252 30.07 7,577
2011-08-25 Bailey Don M (President & CEO) Sale 30,000 26.52 795,450
2011-08-25 Bailey Don M (President & CEO) Option Ex 30,000 1.74 52,200
2011-08-23 Engelke Kristine (Corp. Controller & PAO) Sale 4,000 26.00 104,000
2011-08-23 Engelke Kristine (Corp. Controller & PAO) Option Ex 4,000 10.55 42,200
2011-08-15 Young David (Chief Scientific Officer) Sale 6,092 32.00 194,944
2011-08-15 Young David (Chief Scientific Officer) Option Ex 5,792 1.64 9,498
2011-08-15 Cartt Stephen Lahue (Executive VP & CBO) Sale 47,155 31.50 1,485,382
2011-08-15 Cartt Stephen Lahue (Executive VP & CBO) Option Ex 47,155 1.40 66,017
2011-08-12 Young David (Chief Scientific Officer) Sale 9,308 32.00 297,856
2011-08-12 Young David (Chief Scientific Officer) Option Ex 9,208 1.64 15,101
2011-08-11 Engelke Kristine (Corp. Controller & PAO) Sale 883 31.50 27,814
2011-08-11 Cartt Stephen Lahue (Executive VP & CBO) Sale 85,968 31.10 2,673,174
2011-08-11 Cartt Stephen Lahue (Executive VP & CBO) Option Ex 85,968 1.43 122,934
2011-08-10 Cartt Stephen Lahue (Executive VP & CBO) Sale 25,000 31.00 775,000
2011-08-10 Cartt Stephen Lahue (Executive VP & CBO) Option Ex 25,000 .98 24,500
2011-08-09 Engelke Kristine (Corp. Controller & PAO) Buy 50 29.99 1,499
2011-08-05 Young David (Chief Scientific Officer) Sale 10,000 28.50 285,000
2011-08-05 Young David (Chief Scientific Officer) Option Ex 10,000 1.64 16,400
2011-08-04 Cartt Stephen Lahue (Executive VP & CBO) Sale 25,513 30.17 769,727
2011-08-04 Cartt Stephen Lahue (Executive VP & CBO) Option Ex 25,513 .98 25,002
2011-08-03 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Sale 94,500 31.18 2,946,510
2011-05-20 Silverman Lou (Director) Option Ex 10,000 4.42 44,150
2011-05-16 Cartt Stephen Lahue (Executive VP & CBO) Sale 79,087 22.04 1,743,077
2011-05-16 Cartt Stephen Lahue (Executive VP & CBO) Option Ex 79,087 .98 77,505
2011-05-13 Cartt Stephen Lahue (Executive VP & CBO) Sale 70,400 22.73 1,600,192
2011-05-13 Cartt Stephen Lahue (Executive VP & CBO) Option Ex 70,400 .81 56,812
2011-05-12 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Sale 115,128 22.07 2,540,874
2011-05-03 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Sale 4,500 20.38 91,710
2011-05-02 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Sale 80,372 20.70 1,663,700
2011-04-29 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Sale 204,841 20.36 4,170,562
2011-04-29 Medeiros David Jeffrey (Senior VP, Pharm. Operations) Option Ex 204,841 .81 165,921
2011-04-29 Thompson Virgil D (Director) Sale 167,500 20.38 3,413,650
2011-04-29 Thompson Virgil D (Director) Option Ex 127,500 1.14 144,840
2011-03-08 Blutt Mitchell J Md (Director) Buy 80,000 13.18 1,054,800
2011-03-07 Blutt Mitchell J Md (Director) Buy 145,000 12.95 1,877,895
2011-02-28 Blutt Mitchell J Md (Director) Sale 110,000 12.83 1,411,630
2010-12-01 Thompson Virgil D (Director) Option Ex 45,000 7.58 340,920
2010-11-02 Young David (Chief Scientific Officer) Sale 28,125 12.33 346,893
2010-11-02 Young David (Chief Scientific Officer) Option Ex 28,125 .92 25,959
2010-01-22 Thompson Virgil D (Director) Option Ex 10,000 2.28 22,839
2009-12-04 Thompson Virgil D (Director) Option Ex 10,000 1.06 10,630
2009-11-12 Farrell Stephen C (Director) Buy 30,000 3.50 105,000
2009-08-05 Medeiros David Jeffrey (Snr VP Pharmaceutical Ops) Sale 115,000 6.46 742,440
2009-08-04 Medeiros David Jeffrey (Snr VP Pharmaceutical Ops) Sale 185,000 6.17 1,142,190
2009-08-04 Cartt Stephen Lahue (See Remarks) Sale 100,000 6.12 612,000
2009-08-04 Cartt Stephen Lahue (See Remarks) Option Ex 100,000 .46 46,000
2009-08-03 Cartt Stephen Lahue (See Remarks) Sale 150,000 6.06 908,250
2009-08-03 Cartt Stephen Lahue (See Remarks) Option Ex 150,000 .46 69,000
2008-12-10 Cartt Stephen Lahue (See Remarks) Sale 100,000 9.50 950,000
2008-12-10 Cartt Stephen Lahue (See Remarks) Option Ex 100,000 .46 46,000
2008-12-10 Thompson Virgil D (Director) Sale 52,500 9.40 493,657
2008-12-10 Thompson Virgil D (Director) Option Ex 52,500 .59 30,765
2008-12-03 Halladay Steven (See Remarks) Sale 260,416 8.92 2,323,691
2008-12-03 Halladay Steven (See Remarks) Option Ex 260,416 1.10 286,457
2008-11-07 Bailey Don M (President and CEO) Option Ex 297,612 4.51 1,342,825
2008-11-07 Thompson Virgil D (Director) Sale 4,065 8.69 35,324
2008-11-06 Bailey Don M (President and CEO) Option Ex 385,710 4.60 1,772,337
2008-08-28 Stuart George Michel (CFO & Senior V.P. of Finance) Sale 50,000 5.32 265,750
2008-08-28 Stuart George Michel (CFO & Senior V.P. of Finance) Option Ex 50,000 .50 25,000
2008-08-27 Stuart George Michel (CFO & Senior V.P. of Finance) Sale 50,000 5.30 265,000
2008-08-27 Stuart George Michel (CFO & Senior V.P. of Finance) Option Ex 50,000 .50 25,000
2008-08-25 Stuart George Michel (CFO & Senior V.P. of Finance) Sale 90,000 5.06 455,399
2008-08-25 Stuart George Michel (CFO & Senior V.P. of Finance) Option Ex 90,000 .50 45,000
2008-08-22 Stuart George Michel (CFO & Senior V.P. of Finance) Sale 112,915 5.05 570,220
2008-08-22 Stuart George Michel (CFO & Senior V.P. of Finance) Option Ex 112,915 1.18 132,675
2008-08-13 Chaumiere Consultadoria & Servicos Sdc Unipessoal (10% Owner) Sale 2,200,000 4.95 10,890,000
2008-07-16 Chaumiere Consultadoria & Servicos Sdc Unipessoal (10% Owner) Sale 100,000 4.91 491,399
2008-07-02 Chaumiere Consultadoria & Servicos Sdc Unipessoal (10% Owner) Sale 31,338 5.20 162,957
2008-06-06 Chaumiere Consultadoria & Servicos Sdc Unipessoal (10% Owner) Sale 3,900 5.20 20,280
2008-06-05 Chaumiere Consultadoria & Servicos Sdc Unipessoal (10% Owner) Sale 4,100 5.20 21,320
2008-05-30 Medeiros David Jeffrey (SNR VP PHARMACEUTICAL OPS) Sale 96,070 5.28 507,441
2008-05-30 Cartt Stephen Lahue (EXEC. VP CORPORATE DEVELOPMENT) Sale 100,000 5.30 530,000
2008-05-30 Cartt Stephen Lahue (EXEC. VP CORPORATE DEVELOPMENT) Option Ex 100,000 .46 46,000
2008-05-14 Halladay Steven (See Remarks) Sale 12,000 4.70 56,400
2008-03-18 Cartt Stephen Lahue (See Remarks) Sale 100,000 4.01 401,000
2007-12-14 Thompson Virgil D (Director) Option Ex 10,000 3.61 36,130
2007-12-12 Cartt Stephen Lahue (Executive Vice President) Sale 75,000 5.75 431,250
2007-12-10 Cartt Stephen Lahue (Executive Vice President) Sale 49,602 6.00 297,860
2007-11-20 Inverlochy Consultadoria & Servicos L.d.a. (10% Owner) Buy 2,446,782 4.68 11,450,939
2007-11-20 Inverlochy Consultadoria & Servicos L.d.a. (10% Owner) Sale 2,446,782 4.68 11,450,939
2007-03-15 Bradsher Neal C (Director) Buy 425,300 .76 322,802
2006-12-20 Inverlochy Consultadoria & Servicos L.d.a. (10% Owner) Buy 9,402,890 1.50 14,104,335
2006-12-20 Inverlochy Consultadoria & Servicos L.d.a. (10% Owner) Sale 9,402,890 1.50 14,104,335
2006-12-13 Sigma Tau Finanziaria Spa (10% Owner) Buy 690,000 1.45 1,000,500
2006-09-08 Bailey Don M (Director) Buy 30,900 1.67 51,603
2005-12-16 Hansen Albert (Director) Sale 36,600 1.10 40,260
2005-11-28 Fares James Lawrence (CEO) Buy 146,600 .82 120,065
2005-11-03 Fares James Lawrence (CEO) Buy 40,000 .84 33,800
2005-11-02 Bradsher Neal C (Director) Buy 536,200 .80 427,351
2005-11-01 Medeiros David Jeffrey (VP, Manufacturing) Buy 98,000 .80 78,400
2005-11-01 Fares James Lawrence (CEO) Buy 273,200 .71 194,518
2005-10-31 Cartt Stephen Lahue (Executive Vice Presi) Buy 35,400 .64 22,656
Go to page:  1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of QCOR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Questcor Pharmaceuticals Inc (symbol QCOR, CIK number 891288) see the Securities and Exchange Commission (SEC) website.